KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Abstract Background The molecular profiles of tumors may inform the selection of appropriate targeted therapies. Circulating tumor cells (CTCs) reflect the real-time status of tumor genotypes. CTCs exhibit high genetic heterogeneity within a patient; accordingly, the analysis of individual CTCs, inc...
Main Authors: | Yuurin Kondo, Kazuhiko Hayashi, Kazuyuki Kawakami, Yukari Miwa, Hiroshi Hayashi, Masakazu Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3305-6 |
Similar Items
-
The association between detection the presence of KRAS mutations in tumors and circulating tumor cells from patients with colorectal cancer
by: O. I. Kit, et al.
Published: (2016-02-01) -
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
by: Kim Mi-Jung, et al.
Published: (2012-08-01) -
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
by: Jérôme Alexandre Denis, et al.
Published: (2016-10-01) -
The Prognostic Utility of <i>KRAS</i> Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients
by: Joel Petit, et al.
Published: (2024-01-01) -
KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
by: Olga I. Brovkina, et al.
Published: (2021-03-01)